Compound Detail
CHEMBL4562263
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL4562263 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | SEXLHCZYEYYLOG-UHFFFAOYSA-N |
1
Targets
2
Activities
1
Assay Types
0
PK Parameters
2
Publications
0
Known Names
Molecular Properties
482.6
MW (Da)
6.96
ALogP
7
HBA
2
HBD
91.5
PSA (Ų)
0.36
QED
1
Ro5 Violations
8
Rot. Bonds
Drug Information
| Molecule Type | Unknown |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 2 meas. best 8.4
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Indoleamine 2,3-dioxygenase 1 CHEMBL4685 | IC50 | 8.4 | 8.37 | 4.0 | 2 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Indoleamine 2,3-dioxygenase 1 | IC50 | = | 4.0 | nM | 8.4 | Inhibition of IDO1 in IFN-gamma stimulated human HeLa cells assessed as reductio... | 30858027 |
| Indoleamine 2,3-dioxygenase 1 | IC50 | = | 4.6 | nM | 8.34 | Inhibition of IDO1 in IFN-gamma/LPS stimulated human THP-1 cells assessed as red... | 30858027 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 30858027 | 10.1016/j.bmc.2019.03.005 | Indoleamine 2,3-dioxygenase 1 | 14 |
| 30858027 | 10.1016/j.bmc.2019.03.005 | HeLa | 2 |
Data from ChEMBL 36 via Core Engine